Spinal epidural lipomatosis in children with renal diseases receiving steroid therapy

Kenichi Kano1, Keisho Kyo, Sachio Ito

  • 1Department of Pediatrics, Dokkyo University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsuga-gun, Tochigi 321-0293, Japan. k-kano@dokkyomed.ac.jp

Insights

Steroid-induced spinal epidural lipomatosis (SEL) affects 4% of children on glucocorticoids. Early MRI detection is crucial for obese children with symptoms who receive methylprednisolone pulse therapy.

Area of Science:

  • Pediatric Endocrinology
  • Nephrology
  • Radiology

Background:

  • Spinal epidural lipomatosis (SEL) is a rare condition.
  • Steroid-induced SEL (SSEL) in children is infrequently reported.
  • Two hypotheses exist: steroids induce SEL or promote growth of pre-existing SEL, particularly in obese children.

Purpose of the Study:

  • To investigate the frequency of SSEL in children with renal diseases treated with glucocorticoids.
  • To identify risk factors associated with SSEL in pediatric patients.
  • To evaluate the utility of spinal MRI in early SSEL detection.

Main Methods:

  • Retrospective analysis of 125 children with renal diseases treated with glucocorticoids over 16 years.
  • Investigation of risk factors in 62 SSEL patients from literature.
  • Performance of spinal MRI in patients with early symptoms (back pain, numbness), obesity, or those on methylprednisolone pulse therapy.

Main Results:

  • SSEL was detected in 5 out of 125 children (4.0%).
  • Three of the 5 SSEL patients experienced vertebral compression fractures.
  • All 5 SSEL patients were undergoing methylprednisolone pulse therapy.

Conclusions:

  • SSEL occurs in 4.0% of pediatric renal disease patients on glucocorticoids.
  • Early spinal MRI is recommended for obese children with symptoms receiving methylprednisolone pulse therapy.
  • Prompt diagnosis and management can potentially prevent severe complications like vertebral compression fractures.